KIT and ovarian cancer: Furthermore, CD117 regulates PI3K/Akt, Ras/ERK, Src, and JAK/STAT, and CD117-positive cells have been found to exhibit higher tumorigenicity and resistance in ovarian cancer, making it a potential marker for ovarian CSCs [60].